Reina Kawamura Eiichiro Nagata Masako Mukai Yoichi Ohnuki Tomohiko Matsuzaki Kana Ohiwa Tomoki Nakagawa Mitsutomo Kohno Ryota Masuda Masayuki Iwazaki Shunya Takizawa
10.2169/internalmedicine.8895-17
Intern Med
2017;56(24):3357-3359.
acute cerebellar ataxia immune checkpoint inhibitors nivolumab steroid pulse therapy
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/29249765/
Adenocarcinoma / drug therapy Antibodies, Monoclonal / adverse effects Antineoplastic Agents / adverse effects Cerebellar Ataxia / chemically induced Cerebellar Ataxia / therapy Nystagmus, Pathologic / chemically induced
Adenocarcinoma / drug therapy Antibodies, Monoclonal / adverse effects Antineoplastic Agents / adverse effects Cerebellar Ataxia / chemically induced Cerebellar Ataxia / therapy Nystagmus, Pathologic / chemically induced Case Reports Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Female Humans Lymph Nodes / physiopathology Middle Aged Nivolumab Treatment Outcome Antibodies, Monoclonal Antineoplastic Agents Nivolumab
PMC5790727
29249765
Acute Cerebellar Ataxia Induced by Nivolumab
2017